Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Phase 4CompletedNCT00429520

Merz Pharmaceuticals GmbH114 enrolled

Overview

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

114

Conditions

Nasolabial Folds

Interventions

Hyaluronic acid filler/IMD1 basicDRUG

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * main inclusion criteria: severity rating scale grade 3 or 4 Exclusion Criteria: * main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry

Locations (1)

Merz Pharmaceuticals

Frankfurt, Germany

Outcomes

Primary Outcomes

Severity rating scale assessed by independent rater

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.